Yannick Allanore

2003–2026 年に発表

240
論文数
31,180
被引用数
97
h 指数
228
i10 指数

被引用数

Yannick Allanore の年別被引用数1978 年: 被引用 1 件1982 年: 被引用 1 件1998 年: 被引用 5 件2000 年: 被引用 2 件2004 年: 被引用 3 件2005 年: 被引用 7 件2006 年: 被引用 20 件2007 年: 被引用 32 件2008 年: 被引用 51 件2009 年: 被引用 74 件2010 年: 被引用 121 件2011 年: 被引用 114 件2012 年: 被引用 141 件2013 年: 被引用 132 件2014 年: 被引用 167 件2015 年: 被引用 138 件2016 年: 被引用 161 件2017 年: 被引用 207 件2018 年: 被引用 175 件2019 年: 被引用 1,094 件2020 年: 被引用 1,270 件2021 年: 被引用 1,386 件2022 年: 被引用 1,274 件2023 年: 被引用 808 件2024 年: 被引用 1,306 件2025 年: 被引用 653 件2026 年: 被引用 8 件1979〜1981 年は被引用が無いため表示していません1983〜1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません2001〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,663 件、この内訳の 16.7%イタリア: 引用元論文 918 件、この内訳の 9.2%イギリス: 引用元論文 816 件、この内訳の 8.2%フランス: 引用元論文 751 件、この内訳の 7.6%中国: 引用元論文 610 件、この内訳の 6.1%ドイツ: 引用元論文 608 件、この内訳の 6.1%オランダ: 引用元論文 369 件、この内訳の 3.7%スイス: 引用元論文 360 件、この内訳の 3.6%日本: 引用元論文 338 件、この内訳の 3.4%カナダ: 引用元論文 332 件、この内訳の 3.4%スペイン: 引用元論文 322 件、この内訳の 3.3%ベルギー: 引用元論文 219 件、この内訳の 2.2%
0%16.7%その他 26.5%

分野

  • Medicine85.5%
  • Biochemistry, Genetics and Molecular Biology7.3%
  • Immunology and Microbiology5.4%
  • Neuroscience0.6%
  • Engineering0.3%
  • Health Professions0.2%
  • その他0.7%

トピック

  • Systemic Sclerosis and Related Diseases16.4%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis9.1%
  • Inflammatory Myopathies and Dermatomyositis6.1%
  • Rheumatoid Arthritis Research and Therapies3.7%
  • Pulmonary Hypertension Research and Treatments3.6%
  • Systemic Lupus Erythematosus Research2.8%
  • その他58.3%

共著者

全論文

検索で開く
  1. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David H. Collier, Mary Ellen Csuka, Barri J. Fessler, Serena Guiducci, Ariane L. Herrick, Vivien Hsu, Sergio A. Jiménez, Bashar Kahaleh, Peter A. Merkel, S. Sierakowski, Richard M. Silver, Robert W. Simms, John Varga, Janet Pope - Annals of the Rheumatic Diseases 2013 被引用: 3,406

  2. Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, César Ramos-Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesińska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, Ivan Castellvi Barranco, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen - The Lancet Respiratory Medicine 2020 被引用: 652

  3. Mapping and predicting mortality from systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vanessa Smith, Carolina de Souza Müller, Carlomaurizio Montecucco, Daniela Opriș-Belinski, Francesca Ingegnoli, Panayiotis G. Vlachoyiannopoulos, Bojana Stamenković, Edoardo Rosato, Stefan Heitmann, Jörg H. W. Distler, Thierry Zénone, Matthias Seidel, Alessandra Vacca, Ellen De Langhe, Srđan Novak, Maurizio Cutolo, Luc Mouthon, Jörg Henes, Carlo Chizzolini, Carlos Alberto von Mühlen, Kamal Solanki, Simona Rednic, Lisa K. Stamp, Branimir Anić, Vera Ortiz-Santamaría, Maria De Santis, Şule Yavuz, Walter Alberto Sifuentes Giraldo, Emmanuel Chatelus, Jiří Štork, Jacob M. van Laar, Esthela Loyo, Paloma García de la Peña Lefebvre, Kilian Eyerich, Vanesa Cosentino, Juan José Alegre Sancho, Otylia Kowal‐Bielecka, Grégoire Rey, Marco Matucci‐Cerinic, Yannick Allanore - Annals of the Rheumatic Diseases 2017 被引用: 684

  4. Systemic sclerosis

    著者: , , , , , , - Nature Reviews Disease Primers 2015 被引用: 862

  5. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 被引用: 502

  6. Update of EULAR recommendations for the treatment of systemic sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan Tyndall, Joep Welling, F Wigley, Gabriele Valentini, Ulrich A. Walker, Francesco Zulian, Ulf Müller‐Ladner, Thomas Daikeler, Elisabetta Lanciano, Radim Bečvář, Michal Tomcik, Ewa Gińdzieńska-Sieśkiewicz, Giovanna Cuomo, Michele Iudici, Simona Rednic, Panayiotis G. Vlachoyiannopoulos, Roberto Caporali, Patricia E. Carreira, Servicio de Reumatología, Srdan Novak, Tünde Minier, Eugene J. Kucharz, Armando Gabrielli, Gianluca Moroncini, Paolo Airo', Roger Hesselstrand, Duska Martinovic, Mislav Radić, Daniela Marasovic-Krstulovic, Yolanda Braun-Moscovici, Alexandra Balbir-Gurman, Andrea Lo Monaco, Paola Caramaschi, Jadranka Morović-Vergles, Melanie I. Čulo, Jörg Henes, Vera Ortiz Santamaria, Stefan Heitmann, Dorota Krasowska, Małgorzata Michalska-Jakubus, Matthias F. Seidel, Paul Hasler, Klinik für Rheumatologie, José A. Pereira Da Silva, Maria J. Salvador, Bojana Stamenkovic, Aleksandra Stankovic, Mohammed Tikly, Lidia P. Ananieva, Lorenzo Beretta, Gabriella Szucs, Szilvia Szamosi, Carlos de la Puente Bujidos, Servicio de Reumatología, Øyvind Midtvedt, Anna-Maria Hoffmann-Vold, David Launay, Eric Hachulla, Valeria Riccieri, Ruxandra Ionescu, Daniela Opris, Carina Mihai, Ilka Herrgott, Christian Beyer, Francesca Ingegnoli, Carlos Alberto von Mühlen, Juan José Alegre-Sancho, Emma Beltrán-Catalán, Martin Aringer, Julia Fantana ほか 35 名 - Annals of the Rheumatic Diseases 2016 被引用: 1,116

  7. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 669

  8. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

    著者: , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2020 被引用: 354

  9. Methotrexate and rheumatoid arthritis associated interstitial lung disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Christophe Boissier, Lidwine Wémeau-Stervinou, René‐Marc Flipo, S. Marchand‐Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie‐Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy J. Doyle, Jay H. Ryu, Iván O. Rosas, V. Michael Holers, Cathérine Boileau, Marie‐Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2020 被引用: 236

  10. Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis

    著者: , , , , , , , , , , , , , , , , , - Journal of Scleroderma and Related Disorders 2017 被引用: 521

  11. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Luís Callejas-Rubio, José Antonio Vargas‐Hitos, Rosa García-Portales, M T Camps, Antonio Fernández‐Nebro, Marı́a-Francisca González-Escribano, Francisco José García Hernández, María Jesús Castillo, M. Á. Aguirre, Inmaculada Gómez-Gracia, Benjamín Fernández‐Gutiérrez, Luis Rodríguez‐Rodríguez, Paloma García de la Peña, Esther Vicente, José Luís Andreu, M. Fernández Castro, Francisco Javier López-Longo, Leticia Quintanilla Martinez, Fonollosa, Alberto Guillén, Gerard Espinosa, Carlos Tolosa, A. Pros, Mónica Rodríguez‐Carballeira, Javier Narváez, Manuel Rubio‐Rivas, Ortiz-Santamaría, Ana Belén Madroñero, Miguel Á. González‐Gay, Bianca J. Diaz, Luis Trapiella, André M. M. Sousa, M. V. Egurbide, P. Fanlo-Mateo, Luís Sáez-Comet, Fidel Díez Díaz, Hernández, E. Beltrán, José Andrés Román-Ivorra, Elena Grau, Juan José Alegre Sancho, M. Freire, Francisco J. Blanco, N. Oreiro, Torsten Witte, Alexander Kreuter, G. Riemekasten, Paolo Airó, C. Magro, Alexandre E. Voskuyl, M. C. Vonk, Roger Hesselstrand, Susanna Proudman, Wendy Stevens, Mandana Nikpour, Australian Scleroderma Interest Group (ASIG), Jane Zochling, J. Sahhar, Janet Roddy, Peter Nash, Kathleen Tymms, Maureen Rischmueller, Sue Lester, Timothy J. Vyse, Ariane L. Herrick, Jane Worthington, Christopher P. Denton, Yannick Allanore, Matthew A. Brown, Timothy R. D. J. Radstake ほか 4 名 - Nature Communications 2019 被引用: 188

  12. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    著者: , , , , , , , , , , - Annals of the Rheumatic Diseases 2012 被引用: 364

  13. Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 被引用: 212

  14. Trained immunity modulates inflammation-induced fibrosis

    著者: , , , , , , , , , - Nature Communications 2019 被引用: 153

  15. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 263

  16. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature

    著者: , , , , , , , , , , , , - Arthritis Research & Therapy 2019 被引用: 217

  17. Targeting synovial neoangiogenesis in rheumatoid arthritis

    著者: , , - Autoimmunity Reviews 2017 被引用: 117

  18. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gabriela Riemekasten, Simona Rednic, Edoardo Rosato, Marta Saracco, A Scheja, Vanessa Smith, Carina Mihai, Gabriela Szucs, Matija Tomšič, Gabriele Valentini, Ulrich A. Walker, R Westhovens, Şule Yavuz, Thierry Zénone - Annals of the Rheumatic Diseases 2014 被引用: 428

  19. Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Krieg, R Marcolongo, Ilaria Galetti, Elisabetta Zanatta, Francesco Tona, Petar Seferović, Marco Matucci‐Cerinic - Journal of Scleroderma and Related Disorders 2021 被引用: 75

  20. Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study

    著者: , , , , , , , , , , , , , , , , , - PLoS ONE 2016 被引用: 277

  21. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Cottin, Marie‐Christophe Boissier, B. Wallaert, Thierry Schaeverbeke, F. Moal, Aline Frazier, Christelle Ménard, Martin Soubrier, Nathalie Saidenberg-Kermanac’h, Dominique Valeyre, Serge Amselem, Cathérine Boileau, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2017 被引用: 233

  22. Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit

    著者: , , , , , , - Current Opinion in Rheumatology 2022 被引用: 57

  23. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    著者: , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2010 被引用: 438

  24. EULAR recommendations for the treatment of systemic sclerosis: 2023 update

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2024 被引用: 215